Showing 20 of 74 recruiting trials for “Cholangiocarcinoma”
Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
👨⚕️ Feng Cheng, MD, The First Affiliated Hospital with Nanjing Medical University📍 3 sites📅 Started Jan 2024View details ↗
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)
👨⚕️ Enrico Gringeri, Prof., Azienda Ospedale Università di Padova📍 1 site📅 Started Jan 2024View details ↗
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
RecruitingNCT06140134 ↗
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
👨⚕️ Fei Li, M.D, The First Affiliated Hospital of Nanchang University📍 1 site📅 Started Sep 2023View details ↗
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Sep 2023View details ↗
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
RecruitingNCT06899854 ↗
Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer
👨⚕️ Rutger-Jan Swijnenburg, MD, PhD, Amsterdam UMC, location AMC📍 1 site📅 Started Feb 2023View details ↗
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
👨⚕️ Jonathan M Hernandez, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Mar 2022View details ↗
Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer
👨⚕️ Julien Edeline, MD, Centre de Lutte contre le Cancer Eugène Marquis📍 7 sites📅 Started Feb 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →